PPDI SEC Form 4 filings
Pharmaceutical Product Development Inc Latest Insider Trading Activity
Our insider trading activity tracker for Pharmaceutical Product Development Inc shows 12 total open-market insider transactions for PPDI over the past 5,883 days. The latest displayed record by transaction date reports 2 sales by Colvin Paul (Pharmaceutical Product Development Inc EVP--Clinical Development) totaling 5,759 shares at a weighted-average price of $28.70 per share, with the latest transaction dated May 27, 2011. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.
Insider Trading For PPDI Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. PPDI | 2011-05-27 | 2011-05-27 | Pharmaceutical Product Development Inc | Colvin Paul | EVP--Clinical Development | Sell | 2 | 5,759 | $28.70 | $165,283.30 | 100.00% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. PPDI | 2011-05-23 | 2011-05-20 | Pharmaceutical Product Development Inc | Colvin Paul | EVP--Clinical Development | Sell | 1 | 600 | $29.01 | $17,406.00 | 100.00% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. PPDI | 2011-05-04 | 2011-05-03 | Pharmaceutical Product Development Inc | Hartman Judd | General Counsel | Sell | 1 | 112,476 | $30.23 | $3,400,149.48 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. PPDI | 2011-03-01 | 2011-03-01 | Pharmaceutical Product Development Inc | Magnuson Terry | Director | Sell | 1 | 8,281 | $27.70 | $229,383.70 | 33.83% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. PPDI | 2011-03-01 | 2011-03-01 | Pharmaceutical Product Development Inc | Frank Fred | Director | Sell | 1 | 8,281 | $27.55 | $228,141.55 | 10.42% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. PPDI | 2011-03-01 | 2011-02-28 | Pharmaceutical Product Development Inc | Grange David L | Chief Executive Officer | Sell | 1 | 34,501 | $26.00 | $897,026.00 | 36.11% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. PPDI | 2011-03-01 | 2011-02-28 | Pharmaceutical Product Development Inc | Wilkinson Michael O. | Chief Information Officer | Sell | 1 | 21,667 | $28.19 | $610,792.73 | 92.71% | View Filing |
| DRIP: Dividend reinvestment PPDI | 2011-02-14 | 2011-02-14 | Pharmaceutical Product Development Inc | Wilkinson Michael O. | Chief Information Officer | Sell | 1 | 24,496 | $28.84 | $706,464.64 | 93.50% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. PPDI | 2010-11-04 | 2010-11-03 | Pharmaceutical Product Development Inc | Grange David L | Chief Executive Officer | Sell | 2 | 51,753 | $25.71 | $1,330,677.80 | 29.77% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. PPDI | 2010-08-10 | 2010-08-09 | Pharmaceutical Product Development Inc | Mario Ernest | Director | Sell | 1 | 26,726 | $25.12 | $671,357.12 | 14.28% | View Filing |
⚠️ THE SAMPLE ABOVE IS DEFERRED BY 6 HOURS ⚠️
Start your 2-week, no-credit-card free trial today to receive get down to the second insider trading updates in this directory or email.
Pricing
Free Trial
10 trading days$0
Explore every Premium feature before you pay.
- Full platform access
- 10 trading days
- No credit card required
- 20 years of alert history
- Live alert directory updates
Standard Monthly
Scheduled$19.99 / month
Scheduled alerts with complete trade context.
- Email and Telegram delivery
- Alert intervals from every sixty minutes to once daily
- Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
- Highlighted cluster transactions and SEC filing links
- Access to the alert directory hourly refreshes
Premium Monthly
Recommended$29.99 / month
Fastest alerts with ticker-level control.
- Everything in Standard
- Instant delivery detection-to-outbound time averages 0.90 seconds
- Alert intervals starting from one minute
- Real time alert directory updates
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.